KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Other Non-Current Liabilities: 2009-2025

Historic Other Non-Current Liabilities for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $843.0 million.

  • Bausch Health Companies' Other Non-Current Liabilities rose 4.72% to $843.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $843.0 million, marking a year-over-year increase of 4.72%. This contributed to the annual value of $713.0 million for FY2024, which is 8.12% down from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Other Non-Current Liabilities is $843.0 million, which was down 3.88% from $877.0 million recorded in Q2 2025.
  • Bausch Health Companies' 5-year Other Non-Current Liabilities high stood at $975.0 million for Q2 2021, and its period low was $524.0 million during Q2 2022.
  • Its 3-year average for Other Non-Current Liabilities is $771.2 million, with a median of $751.0 million in 2024.
  • Per our database at Business Quant, Bausch Health Companies' Other Non-Current Liabilities tumbled by 46.26% in 2022 and then skyrocketed by 42.18% in 2023.
  • Quarterly analysis of 5 years shows Bausch Health Companies' Other Non-Current Liabilities stood at $653.0 million in 2021, then increased by 13.48% to $741.0 million in 2022, then rose by 4.72% to $776.0 million in 2023, then decreased by 8.12% to $713.0 million in 2024, then grew by 4.72% to $843.0 million in 2025.
  • Its last three reported values are $843.0 million in Q3 2025, $877.0 million for Q2 2025, and $761.0 million during Q1 2025.